Early Access — free while we kick the tires
EdgarHawk

Hagerman Allison

VP, Product Development

Officer
1 filing analyzed · 1 company · Latest 2026-02-13

Companies

Company Buys Sells Direction
ONCOLYTICS BIOTECH INC ONCY 1 0 Net buying

Activity

February 2026
2026-02-13 ONCOLYTICS BIOTECH INC ONCY
high
Buy
10,000 shares
$8,298
Significance 7/10

VP Product Development Hagerman buys 10,000 ONCY shares at $0.83; 8 other insiders bought within 14 days (cluster)

Hagerman Allison, VP of Product Development, purchased 10,000 shares at $0.83 on 2026-02-12, increasing her holdings to 115,059 shares. This transaction is notable because it is part of a broader pattern: 8 other insiders also bought within the past 14 days, indicating a cluster buy. The timing occurs while the stock trades at $1.06, approximately 25.4% below its 52-week high of $1.42, potentially reflecting a period of valuation repricing. The clustering of insider purchases across multiple executives warrants investor attention as a signal of internal conviction at current price levels, though the stock's modest 30-day and 90-day gains (+1.0% and +1.9% respectively) suggest modest near-term momentum.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access